Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjögren syndrome : a case report
Copyright: Ansumana Mohammed Keita et al..
We here report the case of a 41-year-old female patient with maculopapular rash occurring a week after receiving hydroxychloroquine 400 mg for primary Gougerot-Sjögren syndrome with articular involvement. The patient had more than 1-year history of idiopathic minimal glomerular lesion, effectively treated with corticosteroid therapy. Maculopapular rashes resolved after hydroxychloroquine treatment was stopped and the patient was given hydrocortisone and desloratadine. Our case highlights the importance of prescribing low dose hydroxychloroquine in subjects with a history of kidney disease as well as of raising awareness and educating patients about side effects of hydroxychloroquine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
The Pan African medical journal - 38(2021) vom: 21., Seite 283 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Toxidermie médicamenteuse sous hydroxychloroquine pour traitement systémique d’un syndrome de Gougerot-Sjögren primaire: à propos d’un cas |
|---|
| Beteiligte Personen: |
Keita, Ansumana Mohammed [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 24.06.2021 Date Revised 24.06.2021 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.11604/pamj.2021.38.283.28478 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326705775 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326705775 | ||
| 003 | DE-627 | ||
| 005 | 20231225195154.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.11604/pamj.2021.38.283.28478 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1088.xml |
| 035 | |a (DE-627)NLM326705775 | ||
| 035 | |a (NLM)34122710 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Keita, Ansumana Mohammed |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjögren syndrome |b a case report |
| 246 | 3 | 3 | |a Toxidermie médicamenteuse sous hydroxychloroquine pour traitement systémique d’un syndrome de Gougerot-Sjögren primaire: à propos d’un cas |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.06.2021 | ||
| 500 | |a Date Revised 24.06.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright: Ansumana Mohammed Keita et al. | ||
| 520 | |a We here report the case of a 41-year-old female patient with maculopapular rash occurring a week after receiving hydroxychloroquine 400 mg for primary Gougerot-Sjögren syndrome with articular involvement. The patient had more than 1-year history of idiopathic minimal glomerular lesion, effectively treated with corticosteroid therapy. Maculopapular rashes resolved after hydroxychloroquine treatment was stopped and the patient was given hydrocortisone and desloratadine. Our case highlights the importance of prescribing low dose hydroxychloroquine in subjects with a history of kidney disease as well as of raising awareness and educating patients about side effects of hydroxychloroquine | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Maculopapular rashes | |
| 650 | 4 | |a case report | |
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a primary Gougerot-Sjögren syndrome | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Loratadine |2 NLM | |
| 650 | 7 | |a 7AJO3BO7QN |2 NLM | |
| 650 | 7 | |a desloratadine |2 NLM | |
| 650 | 7 | |a FVF865388R |2 NLM | |
| 650 | 7 | |a Hydrocortisone |2 NLM | |
| 650 | 7 | |a WI4X0X7BPJ |2 NLM | |
| 700 | 1 | |a Zahlane, Mouna |e verfasserin |4 aut | |
| 700 | 1 | |a Benjilali, Laila |e verfasserin |4 aut | |
| 700 | 1 | |a Essaadouni, Lamiaa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Pan African medical journal |d 2008 |g 38(2021) vom: 21., Seite 283 |w (DE-627)NLM20399910X |x 1937-8688 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2021 |g day:21 |g pages:283 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.11604/pamj.2021.38.283.28478 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2021 |b 21 |h 283 | ||